LBF20406AM41: Difference between revisions
No edit summary |
No edit summary |
||
| (18 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
| Line 4: | Line 6: | ||
|LipidBank=XPR7066 | |LipidBank=XPR7066 | ||
|LipidMaps=LMFA08020052 | |LipidMaps=LMFA08020052 | ||
|SysName= | |SysName=N-Morpholine- (cis-5,cis-8,cis-11,cis-14) -eicosatetraenoylamine | ||
|Common Name=&&Arachidonoylmorpholine&&N-Morpholine- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine&& | |||
|Source= | |||
|Chemical Synthesis=This compound was synthesized from arachidonoylchloride and morpholine. [[Reference:Adams_IB:Ryan_W:Singer_M:Thomas_BF:Compton_DR:Razdan_RK:Martin_BR:,J. Pharmacol. Exp. Ther.,1995,273,1172|{{RelationTable/GetFirstAuthor|Reference:Adams_IB:Ryan_W:Singer_M:Thomas_BF:Compton_DR:Razdan_RK:Martin_BR:,J. Pharmacol. Exp. Ther.,1995,273,1172}}]] | |||
|Metabolism= | |||
|Biological Activity={{Image200|LBF20406AM41FT7066.gif}} [[Reference:Adams_IB:Ryan_W:Singer_M:Thomas_BF:Compton_DR:Razdan_RK:Martin_BR:,J. Pharmacol. Exp. Ther.,1995,273,1172|{{RelationTable/GetFirstAuthor|Reference:Adams_IB:Ryan_W:Singer_M:Thomas_BF:Compton_DR:Razdan_RK:Martin_BR:,J. Pharmacol. Exp. Ther.,1995,273,1172}}]] | |||
}} | }} | ||
{{Lipid/Footer}} | |||
Latest revision as of 04:50, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR7066 |
| LipidMaps | LMFA08020052 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20406AM41 |
| Arachidonoylmorpholine | |
|---|---|
| |
| Structural Information | |
| N-Morpholine- (cis-5,cis-8,cis-11,cis-14) -eicosatetraenoylamine | |
| |
| Formula | C24H39NO2 |
| Exact Mass | 373.298079497 |
| Average Mass | 373.572 |
| SMILES | O=C(N(C1)CCOC1)CCCC=CCC=CCC=CCC=CCCCCC |
| Physicochemical Information | |
| This compound was synthesized from arachidonoylchloride and morpholine. Adams_IB et al. | |
 Adams_IB et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
